Fapon launched its innovative one-stop IVD solutions at ADLM 2025 to support laboratories and IVD manufacturers in North America.

Jul 24, 2025•9 days ago

DüsseldorfBiotechnologyManufacturing

Product Description

At the ADLM 2025 event, Fapon unveiled its new mouse-free IgG blocker and advanced antibodies for cardiac marker assays, along with other high-performance diagnostic products tailored for the US market.

Company Information

Company

Fapon

Location

Düsseldorf, North Rhine-Westphalia, Germany

About

Fapon is a global leading life sciences company dedicated to providing integrated solutions and services for diagnostics, biopharma and biotherapy. The Company has grown into a leading supplier in in-vitro diagnostics by integrating IVD total solutions on raw materials, reagents, and innovative open instrument platforms. Fapon's advanced innovations in therapeutics technologies and AI algorithms contribute to a better and healthier world. Supported by a strong global R&D, manufacturing, sales and service network, its products serve more than 2,500 business partners in 68 countries and regions.

Product Launch Insights

Based on market data

Market expansion signals

New product launches often coincide with market expansion initiatives

Fresh market entry

Products launched in the last 30 days have highest engagement rates

Fapon launched its innovative one-stop IVD solutions at ADLM 2025 to support laboratories and IVD manufacturers in North America.

Product Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Product Launch Insights

Related People

Company Information